Cargando…
Rapid response to mycophenolate mofetil in combination with romiplostim in a case of severe refractory immune thrombocytopenia post COVID‐19 vaccination
Vaccine mediated immune mediated thrombocytopenia (ITP) is exceedingly rare. We present a case of a young female who developed severe refractory ITP with multiple bleeding sites post second dose of COVID‐19 vaccination. She was treated with a combination of romiplostim and mycophenolate mofetil that...
Autores principales: | Nutalapati, Snigdha, Gupta, Garima, Hildebrandt, Gerhard C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572335/ https://www.ncbi.nlm.nih.gov/pubmed/34765210 http://dx.doi.org/10.1002/ccr3.5035 |
Ejemplares similares
-
Mycophenolate Mofetil in severe or methotrexate refractory localized scleroderma
por: Martini, G, et al.
Publicado: (2008) -
Successful Treatment of Refractory Thrombocytopenia with Mycophenolate Mofetil in a Patient with Systemic Lupus Erythematosus
por: Chang, Hyun Kyu
Publicado: (2005) -
Refractory pemphigus vulgaris treated with rituximab and mycophenolate
mofetil
por: Biot, Stephanie Del Rio Navarrete, et al.
Publicado: (2014) -
Severe Enteropathy From Mycophenolate Mofetil
por: Jehangir, Asad, et al.
Publicado: (2016) -
Mycophenolate mofetil use in refractory juvenile systemic lupus erythematosus
por: Marques, R, et al.
Publicado: (2010)